Activation-induced cytidine deaminase: in sickness and in health Leonardo Alves de Souza RiosBenjamin CloeteShaheen Mowla Review – Cancer Research 09 August 2020 Pages: 2721 - 2730
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer Qianqian LiXiaodi ZhuRonglan Zhao Review – Cancer Research 05 September 2020 Pages: 2731 - 2741
Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data Anjali LathwalRajesh KumarGajendra Pal Singh Raghava Original Article – Cancer Research 14 July 2020 Pages: 2743 - 2752
Low level expression of human telomerase reverse transcriptase predicts cancer-related death and progression in embryonal carcinoma Marzieh ShahinLeili Saeednejad ZanjaniZahra Madjd Original Article – Cancer Research 17 July 2020 Pages: 2753 - 2775
Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities Jairo RamosChangwon YooDeodutta Roy Original Article – Cancer Research 23 July 2020 Pages: 2777 - 2815
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres Hyeong-Cheol OhJin-Kyoung ShimSeok-Gu Kang Original Article – Cancer Research Open access 25 July 2020 Pages: 2817 - 2828
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data Josias Bastian GroggKym SchneiderChristian Daniel Fankhauser Original Article – Cancer Research Open access 27 July 2020 Pages: 2829 - 2841
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer Daniel BeilnerChristina KuhnHelene Hildegard Heidegger Original Article – Cancer Research Open access 28 July 2020 Pages: 2843 - 2850
Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma Feng WangNing ZhaoChanglian Lu Original Article – Cancer Research 02 August 2020 Pages: 2851 - 2859
Increased expression of IGF-1Ec with increasing colonic polyp dysplasia and colorectal cancer Swethan AlagaratnamMarilena LoizidouBala Ramesh Original Article – Cancer Research 08 August 2020 Pages: 2861 - 2870
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells Sophie L. Kerschner-MoralesMarie KühneJürgen Sonnemann Original Article – Cancer Research Open access 08 August 2020 Pages: 2871 - 2883
DNA CpG methylation in sequential glioblastoma specimens Zoltan KrabothBence GalikBernadette Kalman Original Article – Cancer Research Open access 10 August 2020 Pages: 2885 - 2896
Immunological combination treatment holds the key to improving survival in pancreatic cancer M. H. SodergrenN. MangalN. Habib Review – Clinical Oncology Open access 03 August 2020 Pages: 2897 - 2911
Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis Shuntai ChenYanju BaoBaojin Hua Review – Clinical Oncology 14 August 2020 Pages: 2913 - 2935
Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis Lyujia ChengSongyao ChenYulong He Original Article – Clinical Oncology 25 May 2020 Pages: 2937 - 2947
Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402 Atsushi KudoMasahiro ShinodaAssociation for Clinical Research on Surgery Group Original Article – Clinical Oncology 27 May 2020 Pages: 2949 - 2956
Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer Taiki HakozakiYukio HosomiYusuke Okuma Original Article – Clinical Oncology 27 May 2020 Pages: 2957 - 2966
Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease Dina Ljubas KelecicAntonela LelasZeljko Krznaric Original Article – Clinical Oncology 07 June 2020 Pages: 2967 - 2978
Overall survival benefit of continuing immune checkpoint inhibitors treatment post dissociated response in patients with advanced lung cancer Huijie ZhouYu SunJiang Zhu Original Article – Clinical Oncology 09 June 2020 Pages: 2979 - 2988
Association between various thyroid gland diseases, TSH values and thyroid cancer: a case–control study Leif SchiffmannKarel KostevMatthias Kalder Original Article – Clinical Oncology 09 June 2020 Pages: 2989 - 2994
Impact of comorbidity and relative dose intensity on outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP Masakazu YamamotoIkuko SuzukiKatsushi Tajima Original Article – Clinical Oncology 10 June 2020 Pages: 2995 - 3002
Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma Leon SchönfeldJan B. HinrichsMartha M. Kirstein Original Article – Clinical Oncology Open access 20 June 2020 Pages: 3003 - 3012
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane Dinja T. KrugerMark OpdamEpie Boven Original Article – Clinical Oncology Open access 21 June 2020 Pages: 3013 - 3023
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease Soo Han KimChang-Min ChoiJae Cheol Lee Original Article – Clinical Oncology 24 June 2020 Pages: 3025 - 3036
Children’s physical activity behavior following a supervised physical activity program in pediatric oncology Maxime CaruDaniel CurnierLaurence Kern Original Article – Clinical Oncology 24 June 2020 Pages: 3037 - 3048
Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes Wentong MeiYixuan DingFei Li Original Article – Clinical Oncology 29 June 2020 Pages: 3049 - 3061
Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome Lanlan ZhouYanan LiuXueyi Pan Original Article – Clinical Oncology 02 July 2020 Pages: 3063 - 3074
Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N) Philipp IvanyiCarsten GrüllichOn behalf of the Interdisciplinary working group on renal tumors (IAG-N) of the German Cancer Socity (DKG) Letter to the Editor Open access 20 August 2020 Pages: 3075 - 3078